FineMark National Bank & Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $219K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $206K | Buy |
|
|||||
|
2024
Q3 | $239K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $205K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $207K | Sell |
|
|||||
|
2023
Q1 | $211K | Sell |
|
|||||
|
2022
Q4 | $210K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $263K | Sell |
|
|||||
|
2022
Q1 | $263K | Hold |
|
|||||
|
2021
Q4 | $266K | Sell |
|
|||||
|
2021
Q3 | $255K | Sell |
|
|||||
|
2021
Q2 | $375K | Sell |
|
|||||
|
2021
Q1 | $353K | Buy |
|
|||||
|
2020
Q4 | $354K | Buy |
|
|||||
|
2020
Q3 | $267K | Sell |
|
|||||
|
2020
Q2 | $297K | Hold |
|
|||||
|
2020
Q1 | $276K | Hold |
|
|||||
|
2019
Q4 | $342K | Sell |
|
|||||
|
2019
Q3 | $334K | Buy |
|
|||||
|
2019
Q2 | $297K | Buy |
|
|||||
|
2019
Q1 | $268K | Sell |
|
|||||
|
2018
Q4 | $269K | Buy |
|
|||||
|
2018
Q3 | $269K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $683K | Sell |
|
|||||
|
2015
Q2 | $767K | Buy |
|
|||||
|
2015
Q1 | $831K | Sell |
|
|||||
|
2014
Q4 | $825K | Buy |
|
|||||
|
2014
Q3 | $795K | Buy |
|
|||||
|
2014
Q2 | $857K | Sell |
|
|||||
|
2014
Q1 | $891K | Buy |
|
|||||
|
2013
Q4 | $732K | Buy |
|
|||||
|
2013
Q3 | $639K | Sell |
|
|||||
|
2013
Q2 | $682K | Buy |
|